Horizons in Cancer Research. Volume 87

$250.00

Hiroto S. Watanabe (Editor)

Series: Horizons in Cancer Research
BISAC: MED062000

This book analyzes advances in cancer research. Chapter 1 will highlight the main features regarding the most outstanding contributions around stimuli-responsive lipid-based nanovesicles and the recent advances in their biomedical applications in cancer. Chapter 2 will more closely discuss the involvement of the AGR protein family in EMT and cancer, with a special focus on AGR2. Chapter 3 covers liquid biopsies, immunotherapy, liquid biopsies, and combinational therapies. Chapter 4 discusses data that will allow revealing additional mechanisms of tumor growth and will be the basis for improving existing antitumor treatment regimens in patients with triple receptor-negative breast cancer, which is characterized by a high degree of malignancy. Chapter 5 reviews the EMT process of cervical cancer cells. Chapter 6 discusses youth SHS exposure and how it is a major public health issue worldwide. Chapter 7 analyzes a specific study dealing with breast biopsy and mammograms of benign and malignant lesions. Chapter 8 reviews the development of Pharmacogenomics studies. Chapter 9 provides an overview of the principles and applications of statistical risk stratification in surgery, highlighting its significance in optimizing patient care and enhancing surgical outcomes.

Table of Contents

Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab

 

Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!